Furthermore, it improves cardiovascular function, increases sleep quality, and manages symptoms of dementia [1, 2, 3]
The article treats these as screening questions a provider must ask before the combination is considered at all
The FLOW trial also highlights the renal protective effects of GLP-1RAs, suggesting a close link between renal and cardiovascular benefits, which warrants further mechanistic studies (256)
You should contact your GP to discuss stopping GLP-1 treatment if you are experiencing: Persistent or severe side effects that significantly impact your quality of life, such as ongoing nausea, vomiting, diarrhoea, or abdominal pain that does not improve with time or dose adjustment
Adding cagrilintide to retatrutide may temporarily exacerbate fatigue during the titration phase, particularly if caloric intake drops significantly
Peptide Sciences+1 NNMT is a cytosolic enzyme that catalyzes methyl transfer from S-adenosyl methionine (SAM) to nicotinamide and related substrates